Japan has delayed the approval of an anti-flu drug as a potential coronavirus treatment after interim results from its first randomised clinical trial provided no solid evidence of its effectiveness.
( read original story …)
The Japan News
Japan has delayed the approval of an anti-flu drug as a potential coronavirus treatment after interim results from its first randomised clinical trial provided no solid evidence of its effectiveness.
( read original story …)